Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a phase 3 trial of its sickle cell disease (SCD) therapy mitapivat, sending ...
Whitehawk Therapeutics CEO Dave Lennon presented at TD Cowen’s 46th Annual Healthcare Conference, outlining the company’s ...
NASA announced it had found the source of a helium flow blockage that forced it to roll the Artemis II rocket back from the ...
Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...
Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results